Director - Analytical Chemistry
Eli Lilly and Company, Indiana
Sean Crowe is Director of Analytical Development in the Bioproduct Research and Development group at Eli Lilly and Company. Since joining Lilly's analytical development group in 2018, he has supported a broad portfolio of candidate molecules spanning early- and late-phase development. His primary focus is analytical method and control strategy development for clinical-stage biopharmaceutical products.
Prior to joining Lilly, Sean earned his Ph.D. in Chemistry from the University of Wisconsin–Madison and his B.S./M.S. in Chemistry from DePaul University in Chicago.
Disclosure information not submitted.
Development of an Improved Size Exclusion Chromatography Method for Antibody-RNA Conjugates
Tuesday, July 14, 2026
9:35 AM - 10:05 AM East Coast USA Time